James Gale is the founding partner and managing director of Signet Healthcare Partners. See sector focus and contact routes.
James Gale is the founding partner and managing director of Signet Healthcare Partners, a New York-based growth equity firm he established in 1998, with over 35 years of healthcare investing and finance experience prior to roles at E.F. Hutton & Co. and Gruntal & Co.. His investment thesis targets commercial-stage healthcare companies, focusing on specialty pharmaceuticals, pharmaceutical services (including CDMOs), medical devices, diagnostics, and pharma-focused businesses globally, with a strong emphasis on formulation, development, manufacturing, and commercialization. Signet typically provides growth capital to companies at the commercial stage, actively partnering with management by taking board roles to deliver strategic, commercial, and operational support. While specific check sizes and lead/follow behavior are not publicly detailed, the firm’s latest tracked deal was a $24.0 million Series B investment in Paragonix Technologies in March 2023, and its most recent investment was in NorthX Biologics in May 2025. Notable portfolio companies include Ascendia Pharmaceuticals, Bionpharma Inc. (where Gale serves as Chairman), Lee’s Pharmaceutical Holdin
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like James Gale · Full investor directory · Investor access · Company funding database